Fingerprint
Dive into the research topics of 'Once-weekly risedronate in men with osteoporosis: Results of a 2-Year, placebo-controlled, double-blind, multicenter study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Once-weekly risedronate in men with osteoporosis: Results of a 2-Year, placebo-controlled, double-blind, multicenter study
Steven Boonen, Eric S. Orwoll, Dietrich Wenderoth, Karen J. Stoner, Rachelle Eusebio, Pierre D. Delmas
Research output: Contribution to journal › Article › peer-review
158
Scopus
citations